You are here

Using Enhanced Gene Targeting to Repair the Sickle Cell

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43HL076093-01
Agency Tracking Number: HL076093
Amount: $104,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
SANGAMO BIOSCIENCES, INC. POINT RICHMOND TECH CENTER
RICHMOND, CA 94804
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 FYODOR Urnov
 (510) 970-6000
 FURNOV@SANGAMO.COM
Business Contact
 JANET NIBEL
Phone: (510) 970-6000
Email: JNIBEL@SANGAMO.COM
Research Institution
N/A
Abstract

The primary purpose of this research program is to develop a highly innovative approach for the treatment of sickle cell disease (SCD) by repairing the causative mutation in hematopoietic stem cells (HSCs) from affected individuals. SCD is due to a single

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government